Delaney Dennis R

Position in NVO — Novo Nordisk A S

CIK 1661536 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$587,265

-$9,922 QoQ

Shares Held

12,250

-24.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#660

of 1,348 holders

Holding Since

Mar 2020

18 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Delaney Dennis R holds $23,462,513 across 5 Drug Manufacturers - General names. NVO ranks #4 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	43,754	$11,112,199
2	LLY	ELI LILLY & Co	6,252	$7,498,835
3	ABBV	AbbVie Inc.	15,342	$3,860,660
4	NVO	Novo Nordisk A S This page	12,250	$587,265
5	NVS	Novartis AG	2,575	$403,554

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$587,265	12,250	-24.6%	Shares	Defined	2026-08-21
2026-03-31	$597,187	16,250	0.0%	Shares	Defined	2026-05-14
2025-12-31	$826,800	16,250	-23.6%	Shares	Defined	2026-02-17
2025-09-30	$1,180,270	21,270	-20.4%	Shares	Sole	2025-11-10
2025-06-30	$1,843,522	26,710	+25.0%	Shares	Sole	2025-07-25
2025-03-31	$1,483,236	21,360	+57.8%	Shares	Sole	2025-05-06
2024-12-31	$1,164,710	13,540	-7.0%	Shares	Sole	2025-02-13
2024-09-30	$1,733,063	14,555	-19.7%	Shares	Sole	2024-11-12
2024-06-30	$2,588,589	18,135	-0.0%	Shares	Sole	2024-08-12
2024-03-31	$2,329,176	18,140	-0.1%	Shares	Sole	2024-05-06
2023-12-31	$1,878,652	18,160	-12.1%	Shares	Sole	2024-02-14
2023-09-30	$1,878,820	20,660	+100.0%	Shares	Sole	2023-11-14
2023-06-30	$1,671,703	10,330	-0.2%	Shares	Sole	2023-08-14
2023-03-31	$1,647,894	10,355	-0.1%	Shares	Sole	2023-05-10
2022-12-31	$1,402,798	10,365	0.0%	Shares	Sole	2023-02-09
2022-09-30	$1,032,664	10,365	-1.2%	Shares	Sole	2022-11-08
2020-06-30	$686,885	10,490	0.0%	Shares	Sole	2020-07-28
2020-03-31	$631,498	10,490	—	Shares	Sole	2020-05-07
No filing history on record for this holder in this stock.